PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
0.5414
-0.0987 (-15.42%)
At close: Mar 27, 2026, 4:00 PM EDT
0.5998
+0.0584 (10.79%)
After-hours: Mar 27, 2026, 7:59 PM EDT
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $26.52 million as of March 27, 2026. Its market cap has decreased by -52.80% in one year.
Market Cap
26.52M
Enterprise Value
18.29M
1-Year Change
-52.80%
Ranking
Category
Stock Price
$0.54
Market Cap Chart
Since March 18, 2019, PDS Biotechnology's market cap has decreased from $45.51M to $26.52M, a decrease of -41.74%. That is a compound annual growth rate of -7.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 29.63M | -29.67% |
| Dec 31, 2025 | 42.12M | -30.92% |
| Dec 31, 2024 | 60.98M | -60.56% |
| Dec 29, 2023 | 154.61M | -58.92% |
| Dec 30, 2022 | 376.31M | 63.37% |
| Dec 31, 2021 | 230.35M | 383.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BriaCell Therapeutics | 28.17M |
| Exicure | 28.11M |
| Serina Therapeutics | 27.89M |
| Hyperion DeFi | 27.69M |
| Kyntra Bio | 26.95M |
| CEL-SCI | 26.77M |
| ABVC BioPharma | 25.69M |
| NeuroSense Therapeutics | 25.10M |